Health Outcomes, Healthcare Resource Use, and Economic Burden of Invasive Meningococcal Disease in the United States Among Children Aged <11 Years
Authors:
Open Access
- 21 September 2026
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics - Open
- p. 1-19
Abstract
No abstract availableKeywords
Funding Information
- GSK
This publication has 33 references indexed in Scilit:
- Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and CanadaInfectious Diseases and Therapy, 2025
- Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USAPharmacoEconomics, 2025
- Life After Invasive Meningococcal Disease: Insights from Survivors and Their CaregiversInfectious Diseases and Therapy, 2024
- Initial Experiences with Invasive Meningococcal Disease: Insights from Survivors and Their CaregiversInfectious Diseases and Therapy, 2024
- Understanding the Sequelae of Invasive Meningococcal Disease in the United StatesInfectious Diseases and Therapy, 2024
- Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal DiseaseInfectious Diseases and Therapy, 2021
- Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance DatabaseInfectious Diseases and Therapy, 2021
- Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their CaregiversInfectious Diseases and Therapy, 2018
- Long-term health and socioeconomic consequences of childhood and adolescent onset of meningococcal meningitisEuropean Journal of Pediatrics, 2018
- Impact of a Child's Chronic Illness on Maternal Sleep and Daytime FunctioningArchives of internal medicine (1960), 2006